OR WAIT null SECS
February 01, 2019
Tech transfer is key to succession advancing biopharmaceutical pipeline products from research to preclinical.
January 18, 2019
MilliporeSigma’s use of modified amino acids can simplify the fed-batch process in biomanufacturing.
November 19, 2018
Under the new long-term agreement, Sartorius Stedim Biotech will continue to offer Lonza media and buffer products under non-exclusive terms.
November 02, 2018
This article will explore the requirements for media and supplements needed to maintain newer cell lines, such as those based on human cells and fungal cells.
September 25, 2018
Cell-line quality has a significant impact on biologic drug quality; learn more about this and other upstream challenges at the new bioLIVE launching this year adjacent to CPhI Worldwide 2018.
September 07, 2018
New products were developed as next-generation process intensification technologies, MilliporeSigma reports.
September 04, 2018
A collaboration integrates Sartorius Stedim Biotech’s BIOSTAT STR bioreactors and Repligen’s XCell ATF cell-retention control technology to create simplified, scalable equipment for intensified cell culture.
August 02, 2018
Development costs and time to market continue to put pressure on the biopharma industry, driving the need for innovation in methods and technologies.
July 02, 2018
Biopharma seeks alternatives that meet the needs for next-gen biologic drug production.
This article highlights 15 years of changes in biopharmaceutical manufacturing.